Efficacy of the Three Most Commonly Used MIGS Technologies plus Cataract Surgery and Cataract Surgery Alone Were Evaluated and Compared...
NEVE ILAN, Israel and SALT LAKE CITY, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,”...
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
– Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA – – Femasys is committed...
GREENVILLE, SC, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL)...
MCLEAN, Va., Oct. 03, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Veterans Affairs (VA) has awarded Acentra Health (formerly...
NME is a progressive, typically fatal autoimmune disease characterized by brain inflammation, that has no disease-modifying treatment options availableSAN DIEGO...
Company to Host Cancer R&D Update on October 19, 2023 to Share Latest Details of Multipronged Cancer Program Based on...
Industry Veteran Brings Decades of Experience Driving Growth at Global Biopharmaceutical Solutions OrganizationsMORRISVILLE, N.C., Oct. 03, 2023 (GLOBE NEWSWIRE) --...
Scottsdale, Arizona--(Newsfile Corp. - October 3, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Toronto, Ontario--(Newsfile Corp. - October 3, 2023) - Neural Therapeutics Inc. ("Neural" or the "Company") is pleased to announce the...
Trading Symbol: SPLYToronto, Ontario--(Newsfile Corp. - October 3, 2023) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) ("Safe Supply" or...
Over 5,000 feet of REPELWRAP™ film was produced using Dunmore's commercial manufacturing line.Film production time took minutes on Dunmore equipment...
9th Circuit Court of Appeals Orders DEA to Respond to MMJ's Writ of Mandamus Within 30 DaysWASHINGTON D.C. / ACCESSWIRE...
STOCKHOLM, SWEDEN / ACCESSWIRE / October 3, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
PARSORTIX SYSTEM OUTPERFORMS CURRENT LABORATORY STANDARD FOR DISSEMINATED TUMOUR CELL HARVEST DTCs linked to cancer relapse even after prolonged remissionDTCs...